company

NEVRO AS

1344 HASLUM

Return on Equity
−6,92 %
Current Ratio
0,44
Debt-to-Equity Ratio
−0,29
Key figures (NOK)2022
Revenue842 000
Net Income18 000
Total Assets145 000
Total Equity−260 000
Income (NOK)2022
Revenue842 000
Expenditure825 000
Operating Profit18 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax18 000
Tax0
Net Income18 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets145 000
Total Assets145 000
Total Retained Equity−290 000
Total Equity−260 000
Total Long-Term Debt75 000
Total Current Debt330 000
Total Equity and Debt145 000
Cash flow (NOK)2022
Sales Income842 000
Other Income0
Revenue842 000
Cost of Goods Sold208 000
Salary Costs186 000
Depreciation0
Impairment0
Expenditure825 000
Operating Profit18 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income18 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank60 000
Total Current Assets145 000
Total Assets145 000
Total Equity−260 000
Short-Term Group Debt0
Total Long-Term Debt75 000
Creditors212 000
Unpaid Taxes32 000
Dividends0
Other Current Debt85 000
Total Current Debt330 000
Total Equity and Debt145 000
Financial indicators2022
Return on Equity−6,92 %
Debt-to-Equity Ratio−0,29
Operating Profit Margin2,14 %
Current Ratio0,44
Quick Ratio0,44
Equity Ratio−1,79
Gross Profit Margin75,3 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English